Long-term remission & control of CVD risk factors can reduce the risk of atherosclerosis in lupus; triple APL positivity raises the risk of CVD, study finds.
What Clinicians Should Know About Midfoot Osteoarthritis
Midfoot OA experts offer an overview of a common, but under-recognized, form of OA, & discuss quality of life impacts, treatments, clinical evaluation procedures & the critical need for further research.
Insights into Mechanisms of Anti-Inflammatory Response to Exercise
A recent Proceedings of the National Academy of Sciences study found that high-intensity aerobic exercise may reduce the release of cell-free DNA & tamp down inflammation over time.
Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis Released
New global criteria for pediatric CNO aim to boost research & improve care for this rare autoinflammatory bone disease.
What Rheumatologists Should Know About B Cell Tolerance & Autoimmunity
A recent Arthritis & Rheumatology review article explores the immune system’s mechanism for creating B cells that respond to diverse pathogens while preserving immune tolerance & highlights key insights for rheumatologists.
Insights from an Orthopedic Spine Surgeon
Dr. Jay Reidler, an adult & pediatric orthopedic spine surgeon, shares insights from his field & discusses his collaborations with rheumatologists.
Study: Are TNF Inhibitors Safe for Patients with RA-ILD?
Despite anecdotal reports to the contrary, a large observational study concludes that TNF inhibitors, compared with non-TNF biological or targeted synthetic DMARDs, do not cause higher rates of death or respiratory hospitalization in patients with RA-ILD.
New Guidance on Mental Health Screening in Pediatric Rheumatology
Pediatric rheumatologic diseases are characterized by high rates of anxiety & depression known to impact health-related outcomes. CARRA and the ACR developed guidance statements to assess & manage mental health concerns for youths in pediatric rheumatology practice.
New Patient- & Provider-Focused Resources Focus on Improving Lupus Care
With resources and programs running online and on the ground in 47 states, COIN’s projects are having a massive impact on the field of rheumatology.
Benefits of Early Initiation of Biologic DMARDs in pJIA
The early initiation of biologic disease-modifying anti-rheumatic drugs (DMARDs) may reduce the overall disease burden in patients with polyarticular juvenile idiopathic arthritis (pJIA), according to findings from Ringold et al.
- 1
- 2
- 3
- …
- 345
- Next Page »